Finance

Lists
Q3 2026 earnings • released • EPS beat +10.90% • Revenue beat +2.19%
See results
AVAH:NASDAQ
Aveanna Healthcare Holdings Inc
$11.50
-6.05%
(-0.74) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVAH...
Open
$11.94
High
$12.24
Low
$11.31
Mkt. cap
2.51B
Avg. vol.
2.31M
Volume
4.27M
P/E ratio
9.37
52-wk high
$14.71
52-wk low
$5.93
EPS
$1.23
Beta
2.03
Shares outstanding
218.29M
No. of employees
20K
Open
$11.94
High
$12.24
Low
$11.31
Mkt. cap
2.51B
Avg. vol.
2.31M
Volume
4.27M
P/E ratio
9.37
52-wk high
$14.71
52-wk low
$5.93
EPS
$1.23
Beta
2.03
Shares outstanding
218.29M
No. of employees
20K
News stories
From web sources and news partners
About Aveanna Healthcare Holdings Inc
CEO-
Employees19.5K
Founded2016
HeadquartersAtlanta, Georgia, United States
SectorHealth Care
IndustryHealth care provider
Websiteaveanna.com
Analyst ratings
Based on 6 analysts giving stock ratings to AVAH in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AVAH in the last 3 months.
Highest
Current $11.50
$16.00 (+39.13%)
Average
$15.33 (+33.30%)
Lowest
$15.00 (+30.43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Buy
Maintained
$15.00
+30.4%
11/13/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$16.00
+39.1%
11/13/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$16.00
+39.1%
11/12/2026
Andrew Cooper
Raymond James
Buy
Maintained
$15.00
+30.4%
09/28/2026
Benjamin Rossi
J.P. Morgan
Hold
Reiterated
$15.00
+30.4%
09/14/2026
David S Macdonald
Truist Financial
Hold
Maintained
$15.00
+30.4%
08/24/2026
Unknown Analyst
UBS
Hold
Reiterated
$13.00
+13%
08/14/2026
Unknown Analyst
Deutsche Bank
Buy
Maintained
$16.00
+39.1%
08/14/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/13/2026
Srikripa Devarakonda
Truist Financial
Hold
Reiterated
-
-
06/08/2026
Unknown Analyst
Stephens
Buy
Upgraded
$11.00
-4.3%
05/15/2026
Raj Kumar CFA
Stephens
Buy
Upgraded
$11.00
-4.3%
05/15/2026
John Ransom
Raymond James
Buy
Maintained
$13.00
+13%
03/20/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$10.00
-13%
03/20/2026
Last report
Nov 12, 2026
Fiscal period
Q3 2026
$0.23 / $0.21
+10.90%beat
Revenue / Est. (USD)
695.54M / 680.62M
+2.19%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jan 2026
Apr 2026
Jul 2026
Oct 2026
Revenue
662.48M
647.92M
670.48M
695.54M
Cost of goods sold
455.38M
442.49M
451.96M
-
Cost of revenue
455.38M
442.49M
451.96M
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
129.97M
129.95M
131.16M
-
Operating expense
131.91M
132.99M
134.16M
-
Total operating expenses
587.29M
575.48M
586.11M
-
Operating income
75.19M
72.44M
84.37M
-
Other non operating income
3.68M
4.99M
5.02M
-
EBT including unusual items
39.24M
44.98M
56.47M
-
EBT excluding unusual items
45.26M
48.08M
60.86M
-
Income tax expense
-139.51M
3.32M
16.18M
-
Effective tax rate
-355.48%
7.39%
28.65%
-
Other operating expenses
-788.00K
-
144.00K
-
Net income
178.75M
41.65M
40.29M
-
Net profit margin
26.98%
6.43%
6.01%
6.53%
Earnings per share
0.17
0.18
0.22
0.23
Interest and investment income
1.74M
1.66M
1.26M
-
Interest expense
-35.35M
-31.00M
-29.79M
-
Net interest expenses
-33.61M
-29.34M
-28.53M
-
Depreciation and amortization charges
2.73M
3.04M
2.85M
-
EBITDA
77.52M
75.48M
87.22M
-
Gain or loss from assets sale
1.14M
-24.00K
144.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps